International Journal of Cancer

Cover image for Vol. 142 Issue 8

Editor-in-Chief: Professor Peter Lichter, DKFZ, Germany

Impact Factor: 6.513

ISI Journal Citation Reports © Ranking: 2016: 24/217 (Oncology)

Online ISSN: 1097-0215

Recently Published Issues

See all

Read the Latest from IJC

New Content from IJC

IJC Accepted Articles(accepted manuscripts)
Accepted Articles have been accepted for publication in IJC, but have not undergone the editing and proof-correction process. Accepted Articles are citable by DOI.

IJC Early View(e-pub ahead of print)
Early View articles are definitive in format and presented in advance of print publication.

View These Special Section Selections

Read Now

News

Highlights

Our paper about implementing mandatory cell line authentication at the International Journal of Cancer has just been published in PLOS Biology - a milestone in promoting good scientific practice.

Read the paper here.

Professor Lichter's Top Picks

Read Now

Editor's Choice from IJC


Access the monthly Editor's Choice article FREE!

2018 (Volume 142)


April (Issue 7)

Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol
Nese Unver, Oliver Delgado, Kirubel Zeleke, Amber Cumpian, Ximing Tang, Mauricio S. Caetano, Hong Wang, Hiroyuki Katayama, Hua Yu, Eva Szabo, Ignacio I. Wistuba, Seyed Javad Moghaddam, Samir M. Hanash and Edwin J. Ostrin

March (Issue 6)

Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizumab
Francesco Passiglia, Antonio Galvano, Sergio Rizzo, Lorena Incorvaia, Angela Listì, Viviana Bazan and Antonio Russo

March (Issue 5)

Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance
Wolfgang Gruber, Elisabeth Peer, Dominik P. Elmer, Christina Sternberg, Suzana Tesanovic, Pedro del Burgo, Sonia Coni, Gianluca Canettieri, Daniel Neureiter, René Bartz, Hella Kohlhof, Daniel Vitt and Fritz Aberger

February (Issue 4)

Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability
Shotaro Korehisa, Eiji Oki, Makoto Iimori, Yu Nakaji, Mototsugu Shimokawa, Hiroshi Saeki, Shinji Okano, Yoshinao Oda and Yoshihiko Maehara

Click the button for

Editors' Choice

COPE

IJC COPE JPG

The International Journal of Cancer has been a member of COPE since 2008.

SEARCH

SEARCH BY CITATION